GOLDENWELL BIOTECH, INC. (GWLL) Return on equity 2019–2023
GOLDENWELL BIOTECH, INC. (GWLL) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-139.3%FY2023 · since FY2019: -0.9% → -139.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -139.3% | +349.3 pp |
| FY2022 | -488.6% | -449.8 pp |
| FY2021 | -38.8% | -36.2 pp |
| FY2020 | -2.5% | -1.6 pp |
| FY2019 | -0.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice